Evidence map›Paper›PMID 31139398›Full record

ArticleFood science & nutrition2019

Effect of yellowing time on bioactive compounds in yellow tea and their antiproliferative capacity in HepG2 cells.

Ran An, Lingli Sun, Limin Xiang, Wenji Zhang, Qiuhua Li, Xingfei Lai, Shuai Wen, Mengen Huo, Dongli Li, Shili Sun

Abstract read
In one paragraph

Article in Food science & nutrition, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Ran AnSchool of Biotechnology and Health Sciences Wuyi University Jiangmen China.
Lingli SunGuangdong Academy of Agricultural Sciences/Guangdong Key Laboratory of Tea Resources Innovation & Utilization Tea Research Institute Guangzhou China.
Limin XiangGuangdong Academy of Agricultural Sciences/Guangdong Key Laboratory of Tea Resources Innovation & Utilization Tea Research Institute Guangzhou China.
Wenji ZhangGuangdong Academy of Agricultural Sciences/Guangdong Key Laboratory of Tea Resources Innovation & Utilization Tea Research Institute Guangzhou China.
Qiuhua LiGuangdong Academy of Agricultural Sciences/Guangdong Key Laboratory of Tea Resources Innovation & Utilization Tea Research Institute Guangzhou China.
Xingfei LaiGuangdong Academy of Agricultural Sciences/Guangdong Key Laboratory of Tea Resources Innovation & Utilization Tea Research Institute Guangzhou China.
Shuai WenSchool of Biotechnology and Health Sciences Wuyi University Jiangmen China.
Mengen HuoSchool of Biotechnology and Health Sciences Wuyi University Jiangmen China.
Dongli LiSchool of Biotechnology and Health Sciences Wuyi University Jiangmen China.
Shili SunGuangdong Academy of Agricultural Sciences/Guangdong Key Laboratory of Tea Resources Innovation & Utilization Tea Research Institute Guangzhou China.ORCID https://orcid.org/0000-0003-3062-1185

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Several studies have shown potent antineoplastic effects of tea, which can induce apoptosis and inhibit proliferation of cancer cells. Yellow tea is one of the six major types of tea, and yellowing time, a key factor in its processing, is known to improve its quality and bioactivity. However, the effects of yellowing on the composition of the bioactive substances of tea are poorly understood. We analyzed the biochemical composition and the antioxidant and anticancer activities of the extracts of yellow tea (EYTs) subjected to different yellowing durations. Prolonged yellowing increased the content of water extracts, amino acids, soluble sugars, theaflavins, and nonesterified catechins (

Indexed as

anticancerantioxidationbioactive componentyellowing timeyellow tea

Identifiers

PMID31139398
PMCPMC6526664

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.